House Hearings

House Committee on Energy and Commerce, Subcommittee on Health: Texas v. United States: The Republican Lawsuit and Its Impacts on Americans with Pre-Existing Conditions

On Feb. 6, the House Committee on Energy and Commerce’s subcommittee on health held a hearing on how a federal judge’s ruling in Texas could affect protections of

House Hearings

Oversight and Reform Committee: Examining the Actions of Drug Companies in Raising Prescription Drug Prices
On Jan. 29, the House Committee on Oversight and Reform held a hearing to determine business practices of pharmaceutical manufacturers as well as possible explanations for and solutions to rising drug prices. Find a link to witness testimonies,

This Week: Congress begins hearings on drug issues; Ways and Means focuses on preexisting conditions.

House

Ways and Means Chairman Schedules Hearing Next Week on Preexisting Conditions
The House Ways and Means Committee Chairman Richard Neal (D-MA) announced a hearing on protecting individuals with preexisting conditions to be held on Jan. 29. The hearing is

This Week: The government shutdown continues; Congress finishes organizing and finalizing committee members and begins to focus on the issues. Concern has been raised that the Centers for Medicare and Medicaid Innovation Center is trying to bypass Congress in health policy.

House

Cummings Launches Drug-Pricing Investigation Prior to Hearings
On Jan. 14, House Oversight Committee

This Week: Congress averts government shutdown by passing two-week extension for Continuing Resolution, pushing the funding issues to Dec. 21.

House

Bipartisan, Bicameral Legislators Unveil FDA-Inspired Bill Regulating Diagnostic Tests

On Dec. 6, bipartisan House and Senate members released draft legislation for the Food and Drug Administration (FDA) to regulate in vitro clinical tests, including